Recent Views on Mechanisms for Lowering Sympathetic Tone

Author:

BRODIE BERNARD B.1

Affiliation:

1. From the Laboratory of Chemical Pharmacology, National Heart Institute, National Institutes of Health, Bethesda, Maryland.

Abstract

A picture is gradually unfolding of the molecular structures at nerve endings which synthesize and store norepinephrine and release the amine onto sympathetic receptors. Norepinephrine is formed continuously regardless of sympathetic tone and is stored inside a lipoid membrane. The amine is present in two pools—a reserve pool in granules in equilibrium with a mobile pool which is maintained against a concentration gradient by active transport. MAO controls the amount of norepinephrine in the nerve ending so that at the steady-state level the amine does not freely diffuse onto receptor sites. In the absence of sympathetic tone, norepinephrine can leave the storage compartments by simple diffusion through the lipoid membrane onto MAO. After nerve stimulation the amine is released directly onto the receptor sites and reaches the blood stream in the form of bases. This model for the transducer helps to explain the action of a number of drugs. Amphetamine increases blood pressure by releasing a small amount of norepinephrine at peripheral sympathetic nerve endings. Reserpine lowers blood pressure by inhibiting the norepinephrine pump which maintains the amine in the mobile pool; as a result the peripheral stores of amine are depleted by an uncompensated diffusion of the amine onto MAO. Bretylium and a number of benzyl derivatives of guanidine lower blood pressure by preventing nerve impulses from releasing norepinephrine at sympathetic nerve endings. Guanethidine and a number of phenylethyl guanidine derivatives cause lowering of arterial pressure by depleting the peripheral stores of norepinephrine perhaps through a persistent activation of the physiologic release mechanism. Alpha-methyldopa, α-methyl-metatyrosine, and metaraminol may act in a similar way. Finally, considerable evidence suggests that MAO inhibitors lower blood pressure by exerting a bretylium-like action. They not only prevent guanethidine from releasing norepinephrine but like bretylium they appear to prevent nerve impulses from releasing norepinephrine onto receptors.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference50 articles.

1. Some current views on brain monoamines. In Monoamines et Systeme Nerveux Central. de Ajuriagguerra, J., ed. Geneva;BRODIE B. B.;Georg & Cie S. A.,1962

2. Mechanism of serotonin and catecholamine uptake by platelets;HTGHES F. B.;J. Pharmacol. & Exper. Therap.,1959

3. Effect of Cardiac Glycosides and Inorganic Ions on Binding of Serotonin by Platelets

4. FUKS Z. AND SCHANKER L.: Personal communication 1963.

5. The uptake of labeled norepinephrine by isolated brain and other tissues of the cat

Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Circulatory responses to hypovolemia in the pregnant and nonpregnant sheep after pharmacologic sympathectomy;American Journal of Obstetrics and Gynecology;1986-02

2. Emotions and the autonomic nervous system;Archives of Internal Medicine;1970-12-01

3. The Use and Misuse of Pressor Agents;Anesthesiology;1970-07-01

4. Physiologic responses to noxious head stimuli;Journal of Psychosomatic Research;1968-10

5. Functional Anatomy of Synaptic Transmission;Anesthesiology;1968-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3